TB
Thomas A Bologna
Chief Executive OfficerDirector

Thomas A Bologna insider trades: Response Genetics (RGDX) stock purchases

Chief Executive Officer, Response Genetics Last trade Feb 2, 2012 46 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2007
6
Companies
last trade 2012

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Thomas reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 2, 2012RGDX↑ Buy$150K
May 19, 2011SDIX↑ Buy$5K
Aug 26, 2010ORCH↑ Buy$1K
Aug 25, 2010ORCH↑ Buy$1K
Aug 23, 2010ORCH↑ Buy$1K
Aug 19, 2010ORCH↑ Buy$2K
Sep 3, 2009ORCH↑ Buy$6K
Jun 15, 2009ORCH↑ Buy$2K
Jun 10, 2009ORCH↑ Buy$4K
Jun 8, 2009ORCH↑ Buy$2K
Aug 6, 2008ORCH↑ Buy$7K
Aug 5, 2008ORCH↑ Buy$11K
Nov 7, 2007ORCH↑ Buy$20K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Thomas A Bologna's insider trades

Thomas A Bologna is Chief Executive Officer at Response Genetics (RGDX). Since Nov 7, 2007, Thomas has reported 13 open-market purchases worth $213K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (23 filings), option exercises (12 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RGDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.